ICD-10-CM Billable Code

O28.1

Abnormal biochemical finding on antenatal screening of mother

Clinical Classification Guidelines

Medical Intelligence & Overview

An abnormal biochemical finding during antenatal screening refers to unexpected results in blood tests or other lab analyses conducted during pregnancy. These findings can indicate potential health concerns for the mother or the developing baby. When such abnormal results are identified, healthcare providers may recommend further tests or monitoring to determine the significance and to plan appropriate care.

Causes & Symptoms

Clinical Causes: Hormonal imbalances that affect pregnancy Underlying maternal conditions such as diabetes or thyroid disorders Nutritional deficiencies Genetic factors influencing biochemical markers Placental issues impacting biochemical parameters Infections affecting maternal health Laboratory errors or variations in testing

Key Symptoms: Often no specific symptoms related directly to biochemical abnormalities Possible signs of underlying conditions, such as fatigue, unusual weight changes, or swelling Indicators of complications may include abnormal fetal growth or development issues

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves analyzing blood samples and other lab tests conducted during routine antenatal screening. When results show abnormalities, healthcare providers may order additional tests such as ultrasound, detailed biochemical panels, or genetic testing to understand the underlying cause. Medical history and physical examination also play key roles in the assessment process.

Treatment Protocols: Treatment depends on the specific abnormality identified and its underlying cause. Management strategies may include adjusting maternal medications, nutritional support, treating any diagnosed infections, or monitoring the pregnancy more closely. In some cases, referral to specialists such as endocrinologists or maternal-fetal medicine experts may be recommended. The goal is to ensure optimal health for both mother and baby throughout pregnancy.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is O28.1 a billable ICD-10 code?
Yes, O28.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report O28.1?
Clinical documentation must specify the nature of Abnormal biochemical finding on antenatal screening of mother and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

abnormal screening mother finding biochemical antenatal